Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
CAMPTOTHECIN DERIVATIVE AND LIGAND-DRUG CONJUGATE
Document Type and Number:
WIPO Patent Application WO/2023/217227
Kind Code:
A1
Abstract:
The present disclosure relates to a ligand-drug conjugate of a novel structure or a pharmaceutically acceptable salt thereof. Specifically, the present disclosure provides a ligand-drug conjugate having a structural general formula represented by Pc-(L-D)n or a pharmaceutically acceptable salt thereof, a method for preparing same, a pharmaceutical composition comprising the conjugate, and use thereof in treating a tumor.

Inventors:
FU YAYUAN (CN)
LI ZHEN (CN)
CHEN CHANGYAN (CN)
CHAI XIAOJUAN (CN)
YU ZHIYONG (CN)
TANG FENG (CN)
CAO ZHUOXIAO (CN)
TANG RENHONG (CN)
Application Number:
PCT/CN2023/093503
Publication Date:
November 16, 2023
Filing Date:
May 11, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SIMCERE ZAIMING PHARMACEUTICAL CO LTD (CN)
International Classes:
A61K47/68; A61P35/00; C07D491/22; C07K16/28
Domestic Patent References:
WO2021067820A12021-04-08
WO2021067861A12021-04-08
Foreign References:
CN112512592A2021-03-16
US20210101982A12021-04-08
Other References:
WEI LI, KAREN H. VEALE, QIFENG QIU, KERSTIN W. SINKEVICIUS, ERIN K. MALONEY, JULIET A. COSTOPLUS, JANET LAU, HELEN L. EVANS, YULIU: "Synthesis and Evaluation of Camptothecin Antibody-Drug Conjugates", ACS MEDICINAL CHEMISTRY LETTERS, AMERICAN CHEMICAL SOCIETY, US, vol. 10, no. 10, 10 October 2019 (2019-10-10), US , pages 1386 - 1392, XP055758576, ISSN: 1948-5875, DOI: 10.1021/acsmedchemlett.9b00301
Attorney, Agent or Firm:
INSIGHT INTELLECTUAL PROPERTY LIMITED (CN)
Download PDF: